E2031

Eliprodil

≥98% (HPLC), powder

• Synonim(y): α-(4-Chlorophenyl)-4-[(4-fluorophenyl)methyl]-1-piperidineethanol, SL 820715
• Wzór empiryczny (zapis Hilla): C₂₀H₂₃ClFNO
• Numer CAS: 119431-25-3
• Masa cząsteczkowa: 347.85
• NACRES: NA.77
• PubChem Substance ID: 24277709
• UNSPSC Code: 12352200
• MDL number: MFCD00866651
• Assay: ≥98% (HPLC)
• Form: powder

Właściwości

• Quality Segment: 200
• assay: ≥98% (HPLC)
• form: powder
• color: white to beige
• solubility: DMSO: 5 mg/mL, clear, H₂O: insoluble
• originator: Sanofi Aventis
• storage temp.: 2-8°C
• SMILES string: OC(CN1CCC(CC1)Cc2ccc(F)cc2)c3ccc(Cl)cc3
• InChI: 1S/C20H23ClFNO/c21-18-5-3-17(4-6-18)20(24)14-23-11-9-16(10-12-23)13-15-1-7-19(22)8-2-15/h1-8,16,20,24H,9-14H2
• InChI key: GGUSQTSTQSHJAH-UHFFFAOYSA-N
• Gene Information: human ... GRIN2B(2904) ; rat ... Adra1a(29412)

Opis

Biochem/physiol Actions

NR2B selective NMDA glutamate receptor antagonist which appears to target the "polyamine site" on the NMDA receptor, setting it apart from other NR2B receptor antagonists. Possesses neuroprotective effects in models of ischemia, but prolongs the QT interval in patients; currently under investigation for acute and chronic pain.

NR2B selective NMDA glutamate receptor antagonist.

Features and Benefits

This compound was developed by Sanofi Aventis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• Klasa składowania: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable
• ppe: Eyeshields, Gloves